Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients.

Autor: Homin Kang1, Jungyo Suh1, Dalsan You1, In Gab Jeong1 lbj1986@hanmail.net, Bumsik Hong1, Jun Hyuk Hong1, Hanjong Ahn1, Bumjin Lim1
Zdroj: Investigative & Clinical Urology. May2024, Vol. 65 Issue 3, p256-262. 7p.
Databáze: Academic Search Ultimate